论文部分内容阅读
为了验证“瑞特恩”的改善性功能作用和强壮效应，用随机抽样及双盲法设立双对照组和实验组，对126例肾阳虚型功能性阳展患者进行临床试验。结果，临床实验中，安雄丸组有效率为56．7％，瘘必治组为57．5％，瑞恩特组为87．3％，两对照组与瑞特恩组比较，P值均＜0．01。动物实验中性行为试验及强壮效应观察，实验组、毒理组与模型组比较，分别有差异及显著性差异；与正常组比较无差异。血清性激素测定，各组间均无差异。结果表明瑞特恩有明显增强性行为和体力作用，可用于治疗肾阳虚型功能性阳痿患者，并可预防耗竭性死亡，且不干预体内性激素水平。
In order to verify the “Ryten” improved sexual function and strong effect, a randomized and double-blind method was used to establish a double-control group and an experimental group. 126 cases of patients with functional Yang-deficiency Yangyang deficiency were clinically tested. As a result, in the clinical trials, the effective rate of the Anxiong Pills group was 56.7%, that of the Qizhizhi group was 57.5%, and that of the Reynolds group was 87.3%. The P values of the two control groups were similar to those of the Reiter group. <0.01. In animal experiments, sexual behavior tests and strong effects were observed. There were significant differences between the experimental group and the toxicology group compared with the model group; there was no difference between the experimental group and the normal group. There was no difference in serum hormone levels between groups. The results show that Reutn has significant sexual and physical effects and can be used to treat patients with functional impotence due to kidney-yang deficiency and to prevent depleted death without interfering with sex hormone levels in vivo.